Show simple item record

dc.contributor.author Λυκερίδου - Αβραμιώτη, Κατερίνα el
dc.contributor.author Γουρουντή, Κλεάνθη el
dc.contributor.author Κούρτης, Πλούταρχος, Χ. el
dc.date.accessioned 2015-05-19T15:40:45Z
dc.date.issued 2015-05-19
dc.identifier.uri http://hdl.handle.net/11400/10739
dc.rights Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες *
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/us/ *
dc.source http://pharmakonpress.gr/ el
dc.subject Ultrasound
dc.subject Fetal nasal bone
dc.subject Down syndrome
dc.subject Screening
dc.subject Υπέρηχος
dc.subject Ρινικό οστό εμβρύου
dc.subject Σύνδρομο Down
dc.title Nasal bone as an ultrasonographic marker for down syndrome en
heal.type journalArticle
heal.classification Medicine
heal.classification Midwifery
heal.classification Ιατρική
heal.classification Μαιευτική
heal.classificationURI http://id.loc.gov/authorities/subjects/sh00006614
heal.classificationURI http://id.loc.gov/authorities/subjects/sh96006072
heal.classificationURI **N/A**-Ιατρική
heal.classificationURI **N/A**-Μαιευτική
heal.keywordURI http://id.loc.gov/authorities/subjects/sh85039232
heal.dateAvailable 10000-01-01
heal.language en
heal.access forever
heal.recordProvider Σχολή Επαγγελμάτων Υγείας και Πρόνοιας. Τμήμα Μαιευτικής el
heal.publicationDate 2004
heal.bibliographicCitation Lykeridou, K., Gourounti, K. and Kourtis, P. (2004) Nasal bone as an ultrasonographic marker for down syndrome. "Epitheorese Klinikes Farmakologias kai Farmakokinetikes", 18 (3), p. 255-260. Available from: http://pharmakonpress.gr/?p=5723 [Accessed: 19/05/2015]. en
heal.abstract The objective of this review article is to inform about the role of the ultrasonographic appearance of the fetal nasal bone in the prenatal screening for the diagnosis of the Down syndrome. During the pregnancy the identification of affected fetuses is dependent on sonographic markers, such as nuchal translucency, nuchal fold, pyelectasis, hyperechoic bowel, echogenic intracardiac foci. Today the appearance of the fetal nasal bone can be used as a new promising ultrasonographic marker for the Down syndrome during the pregnancy. Normally the fetal nasal bone is sonographically apparent at 11 weeks of gestation and the fetal nasal bone length increases with the increase of the crown-rump rump length of the fetus. The absence or the hypoplasia of a nasal bone is associated with a high risk for trisomy 21 and it is a highly sensitive and specific marker for this chromosomal abnormality. Recently the nasal bone has been shown to be absent in the majority of the fetuses with Down syndrome, compared with a small percentage of normal fetuses. Therefore a short or an absent nasal bone is associated with an increased likelihood ratio for fetal Down syndrome. The addition of the fetal nasal bone in the prenatal screening for the detection of the Down syndrome can increase the detection rate and decrease the false positive rate. en
heal.publisher Πλέσσα, Ελένη Σ. el
heal.journalName Epitheorese Klinikes Farmakologias kai Farmakokinetikes en
heal.journalType peer-reviewed
heal.fullTextAvailability false


Files in this item

Files Size Format View

There are no files associated with this item.

The following license files are associated with this item:

Show simple item record

Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες Except where otherwise noted, this item's license is described as Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες